AMINOSYN 7% W/ ELECTROLYTES
LOE Approachingamino acids; magnesium chloride; potassium phosphate, dibasic; sodium chloride
NDAINJECTIONINJECTABLE
Approved
May 1976
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 21h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
AMINOSYN 7% W/ ELECTROLYTES is an injectable amino acid formulation with essential electrolytes (magnesium, potassium, sodium) designed for parenteral nutritional support. It provides essential amino acids and electrolyte balance for patients unable to consume nutrition orally or enterally, supporting protein synthesis and metabolic homeostasis. This is a foundational nutritional therapy product used across acute care, ICU, and chronic care settings.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30%), indicating consolidation and cost-management focus rather than growth.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on AMINOSYN offers stability in a legacy product with established market presence, but limited upside growth or innovation opportunities. Career progression here favors operational excellence, cost management, and field execution rather than strategic expansion or clinical differentiation.
Supply Chain ManagerHospital Account Manager
Worked on AMINOSYN 7% W/ ELECTROLYTES at ICU Medical? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.